mRNA Stock Shock: Moderna’s Nasdaq-100 Entry Sparks Forced Buying Frenzy or Post-Rebalance Fade?
Moderna replaces Warner Bros Discovery in the Nasdaq-100 effective 2026, triggering forced passive buying for the mRNA stock. Inclusion boosts liquidity and visibility, but history...
